WO2001004284A1 - Cellobiohydrolase reduced glycosylation variants: cbhin45a; cbhin270a; and cbhin384a - Google Patents
Cellobiohydrolase reduced glycosylation variants: cbhin45a; cbhin270a; and cbhin384aInfo
- Publication number
- WO2001004284A1 WO2001004284A1 PCT/US2000/019007 US0019007W WO0104284A1 WO 2001004284 A1 WO2001004284 A1 WO 2001004284A1 US 0019007 W US0019007 W US 0019007W WO 0104284 A1 WO0104284 A1 WO 0104284A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gly
- thr
- ser
- asn
- ala
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01091—Cellulose 1,4-beta-cellobiosidase (3.2.1.91)
Definitions
- This invention relates to exoglucanases. More specifically, it relates to Trichoderma reesei cellobiohydrolase I reduced glycosylation variants which enable expression of the active enzyme in a heterologous host.
- pretreatment heats the substrate past the phase-transition temperature of lignin; and (2) pretreated biomass contains less acetylated hemicellulose.
- pretreated biomass contains less acetylated hemicellulose.
- pretreated biomass contains displaced and modified lignin. This alteration results in a non-specific binding of the protein with the biomass, which impedes enzymatic activity.
- pretreated biomass is a hardwood-pulp it contains a weak net-negatively charged surface, which is not observed in native wood. Therefore, for the efficient production of ethanol from pretreated biomass it is desirable to enhance the catalytic activity of glycosyl hydrolases on acid hydrolyzed hardwoods.
- Trichoderma reesei CBH I is a mesophilic cellulase enzyme, and comprises a major catalyst in the overall hydrolysis of cellulose.
- An artificial ternary cellulase system consisting of a 90: 10:2 mixture of T. reesei CBH I, A. cellulotyticus ⁇ l, and A. niger ⁇ -D-glucosidase is capable of releasing as much reducing sugar from pretreated yellow poplar as the native T. reesei system after 120 h.
- T. reesei CBH I variant enzymes capable of active expression in a heterologous host.
- the heterologous host Aspergillus awamori could provide an excellent capacity for synthesis and secretion of T. reesei CBH I because of its ability to correctly fold and post-translationally modify proteins of eukaryotic origin.
- A. awamori is believed to be an excellent test-bed for Trichoderma coding sequences and resolves some of the problems associated with direct site directed mutagenesis in Trichoderma.
- Another object of the invention is to provide a variant exoglucanase characterized by a reduction in glycosylation when expressed in a heterologous host.
- Another object of the invention is to provide an active cellobiohydrolase enzyme capable of expression in heterologous fungi or yeast. It is yet another object of the invention to provide a method for reducing the glycosylation of a cellobiohydrolase enzyme for expression in a heterologous host.
- the invention provides a method for making an active exoglucanase in a heterologous host, the method comprising reducing glycosylation of the exoglucanase, reducing glycosylation further comprising replacing an N-glycosylation site amino acid residue with a non- glycosyl accepting amino acid residue.
- the invention further provides a cellobiohydrolase, comprising the reduced glycosylation variant cellobiose enzymes CBHTN45 A; CBHIN270A; or CBHIN384A, or any combination thereof.
- a method for reducing the glycosylation of an expressed Trichoderma reesei CBHI protein by site-directed mutagenesis is disclosed.
- the method includes replacing an N- glycosylation site amino acid residue, such as asparagines 45, 270, and/or 384 of SEQ. ID NO: 4 (referenced herein as CBHTN45A, CBHIN270A and CBHTN384A, respectively), with a non- glycosyl accepting amino acid residue, such as is alanine.
- Various mutagenesis kits for SDM are available to those skilled in the art and the methods for SDM are well known.
- CBHIN45A discloses a procedure for making and using CBHI variants: CBHIN45A; CBHIN270A; and CBHIN384A.
- the examples below demonstrate the expression of active CBH I in the heterologous fungus Aspergillus awamori.
- Trichoderma reesei Trichoderma reesei.
- the cbhl genes included both cDNA and genomic (intron containing) versions. These were altered by site-directed mutagenesis for the specific purpose of reducing the glycosylation of the expressed CBH I protein through replacement of the N-glycosylation site amino acid residues (asparagine) with non-glycosyl accepting amino acid residues (alanine).
- the gene was propagated in an E. coli vector plasmid (pPFE2) under the control of the Aspergillus awamori glucoamylase promoter and signal sequence, and trpC terminator, and carrying resistance to ampicillin (E. coli selection) and Zeocin (Bleomycin) Aspergillus selection.
- CBHIN270A SEQ. ID. NO: 2
- CBHIN270A SEQ. ID. NO: 2
- CBHIN45A SEQ. ID. NO: 1
- CBHTN384A SEQ. ID. NO: 3
- Example 1 Production of Active Recombinant CBH I (rCBH I) in Aspergillus awamori Construction of Modified CBH I Coding Sequence.
- the coding sequence for T. reesei CBH I (SEQ. ID. NO: 4) was successfully inserted and expressed in Aspergillus awamori using the fungal expression vector pPFE2 (and pPFEl).
- Vectors pPFEl and pPFE2 are£. coli-Aspergillus shuttle vectors, and contain elements required for maintenance in both hosts. They encode ampicillin resistance for selection in E. coli and Zeocin resistance for selection in Aspergillus.
- the foregoing provided for the site-directed mutagenesis in E. coli, followed by expression of the new mutant proteins in A. awamori.
- the foregoing provided for the site-directed mutagenesis in E. coli, followed by expression of the new mutant proteins in A. awamori.
- CBH I gene is under the control of the A. awamori glucoamylase promoter and includes the glucoamylase secretion signal peptide.
- the construction of this plasmid required the addition, by PCR, of a Notl site and Xbal site on the coding sequence of CBH 1.
- the Notl site addition resulted in a change of the most N- terminal amino acid on the protein from glutamine to glycine. This glycine was subsequently changed back to the native glutamine in the pPFE2/CBHI construct, using site-directed mutagenesis PCR. This new construct was used to transform A.
- rCBH I rCBH I expressed in A. awamori tends to be over glycosylated as evidenced by the higher molecular weight observed on western blot analysis.
- Over-glycosylation of CBH I by A. awamori was confirmed by digestion of the recombinant protein with endoglycosidases. Following endoglycosidase H and F digestion, the higher molecular weight form of the protein collapses to a molecular weight similar to native CBH 1.
- the vector pPFE2/CBHI requires a relatively long PCR reaction (8.2 kb) to make site- specific changes using the Stratagene Quik Change protocol.
- the PCR reaction was optimized as follows using a GeneAmp PCR System 2400, Perkin Elmer Corporation.
- the reaction mixture contained 50 ng of template DNA, 125 ng each of the sense and antisense mutagenic primers, 5 ⁇ l of Stratagene lOx cloned Pfu buffer, 200 ⁇ M of each: dNTP, 5 mM MgCl 2 (total final concentration Of MgCl 2 is 7 mM); and 2.5 U Pfu Turbo DNA polymerase.
- the PCR reaction was carried out for 30 cycles, each consisting of one minute denaturation at 96C°, 1 minute annealing at 69°C, and 20-minute extension at 75°C. There is an initial denaturation for 2 minutes at 96°C and a final extension for 10 minutes at 75°C, followed by a hold at 4°C. Agarose gel electrophoresis, ethidium bromide staining, and visualization under UV transillumination were used to confirm the presence of a PCR product.
- PCR products were digested with restriction enzyme Dpnl, to degrade un-mutagenized parental DNA, and transformed into E. coli (Stratagene Epicurian Coli Supercompetent XL-1 Cells). Amp R colonies were picked from LB-Amp 100 plates and mutations were confirmed by DNA sequencing. Depending on scale, plasmid DNA was purified using the Qiagen QiaPrep Spin Miniprep Kit or the Promega Wizard Plus MaxiPrep DNA Purification System.
- spores were inoculated into 50 mL CM maltose medium, pH 5 0, and grown at 32°C, 225 rpm in 250 mL baffled flasks The cultures were transferred to 1 0 L of CM maltose in 2,800 mL Fernbach flasks and grown under similar conditions For large-scale enzyme production (>1 mg), these cultures were transferred to 10-L CM maltose in a New Brunswick BioFlo3000 chemostat (10-L working volume) maintained at 20% DO; pH 4 5, 25°C, and 300 rpm. The culture was harvested by filtration through Miracloth after 2-3 days of growth.
- the filtrate was concentrated and dia-flltered into 20mM sodium acetate pH 5.0 by tangential flow ultrafiltration with an Amicon DC30 concentrator equipped with a single 10,000 MWCO hollow fiber cartridge (1.1mm I D., 2.4 m 2 surface area).
- the retentate from the 10-L concentration or the filtrate from smaller cultures was clarified in an
- the permeate was further concentrated with an Amicon CH-2 concentrator equipped with three 10,000 MWCO hollow fiber cartridges (1.1 mm I D., 0.03 m 2 surface area). The final concentrate was sterile filtered through a 0.45 ⁇ m filter and stored at 4°C until used.
- the recombinant CBH I protein SEQ. ID NO: 4, was purified by passing the concentrated culture broth over two or three CBinD900 cartridge columns (Novagen, Madison,
- the eluted rCBH I was concentrated in an Amicon 10 mL stirred cell using a 25 mm PM10 membrane to ⁇ 2.0 mL and loaded onto a Pharmacia SuperDex200 16/60 size-exclusion column.
- the mobile phase was: 20 mM sodium acetate; 100 mM sodium chloride; and 0.02% sodium azide, pH 5.0 running at 1.0 mL/min.
- the eluted protein was concentrated by stirred cell and stored at 4°C. Concentration was determined by A 28 o using the extinction coefficient and molecular weight calculated for individual proteins by the ProtParam tool on the ExPASy website
- Example 2 Production of Reduced Glycosylation rCBH 1: Sites N270A: N45A: and N384A.
- rCBHl/pPFE2 has been optimized using site-directed mutagenesis to achieve expression of native molecular weight CBH I in A awamori.
- the QuickChange SDM kit (Stratagene, San Diego, Ca) was used to make point mutations, switch amino acids, and delete or insert amino acids in the native CBH1 gene sequence.
- the Quick Change SDM technique was performed using thermotolerant Pfu DNA polymerase, which replicates both plasmid strands with high fidelity and without displacing the mutant oligonucleotide primers.
- the procedure used the polymerase chain reaction (PCR) to modify the cloned CBH1 DNA.
- the basic procedure used a supercoiled double stranded DNA (dsDNA) vector, with an insert of interest, and two synthetic oligonucleotide primers containing a desired mutation.
- the oligonucleotide primers each complimentary to opposite strands of the vector, extend during temperature cycling by means of the polymerase. On incorporation of the primers, a mutated plasmid containing staggered nicks was generated. Following temperature cycling, the product was treated with a Dpnl restriction enzyme.
- Dpnl is specific for methylated and hemi-methylated DNA and thus digests the unmutated parental DNA template, selecting for the mutation-containing, newly-synthesized DNA.
- Three glycosylation-site amino acids on the protein surface were targeted for substitution of an alanine (A) residue in place of asparagine (N). Single site substitutions were successfully completed in the CBH I coding sequence at sites N45, N270, and N384, of SEQ. ID NO.: 4 by site-directed mutagenesis, and confirmed by DNA sequencing.
- Table 1
- variants CBHIN45A SEQ. ED NO: 1
- CBHI384A SEQ. ED NO.: 3
- Double and triple combinations of this substitution have also been completed in the CBH I coding sequence (SEQ. ED NO.: 4) at sites N45, N270, and N384 by site-directed mutagenesis and confirmed by DNA sequencing. These double and triple-site constructs will also yield rCBH I enzymes with reduced glycosylation and, presumably, native activity.
- GGC AAATGTGATTTCC AAGCGCC AGTCGGCCTGC ACTCTCC antisense strand
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002379326A CA2379326A1 (en) | 1999-07-13 | 2000-07-13 | Cellobiohydrolase reduced glycosylation variants: cbhin45a; cbhin270a; and cbhin384a |
AU62108/00A AU6210800A (en) | 1999-07-13 | 2000-07-13 | Cellobiohydrolase reduced glycosylation variants: cbhin45a; cbhin270a; and cbhin384a |
EP00948637A EP1200574A4 (en) | 1999-07-13 | 2000-07-13 | Cellobiohydrolase reduced glycosylation variants: cbhin45a; cbhin270a; and cbhin384a |
US12/123,352 US8637293B2 (en) | 1999-07-13 | 2008-05-19 | Cellobiohydrolase I enzymes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14371199P | 1999-07-13 | 1999-07-13 | |
US60/143,711 | 1999-07-13 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/031,496 Continuation US7375197B2 (en) | 1999-07-13 | 2002-01-14 | Cellobiohydrolase I gene and improved variants |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001004284A1 true WO2001004284A1 (en) | 2001-01-18 |
Family
ID=22505256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/019007 WO2001004284A1 (en) | 1999-07-13 | 2000-07-13 | Cellobiohydrolase reduced glycosylation variants: cbhin45a; cbhin270a; and cbhin384a |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1200574A4 (en) |
AU (1) | AU6210800A (en) |
CA (1) | CA2379326A1 (en) |
WO (1) | WO2001004284A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003000941A3 (en) * | 2001-06-26 | 2004-03-25 | Novozymes As | Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
EP1578943A2 (en) * | 2002-08-16 | 2005-09-28 | Genencor International, Inc. | NOVEL VARIANT i HYPROCREA JECORINA /i CBH1 CELLULASES |
EP1606392A2 (en) * | 2003-03-21 | 2005-12-21 | Genencor International, Inc. | Novel cbh1 homologs and variant cbh1 cellulases |
EP1660637A2 (en) * | 2003-08-25 | 2006-05-31 | Novozymes Inc. | Variants of glycoside hydrolases |
JP2007521797A (en) * | 2003-05-29 | 2007-08-09 | ジェネンコー・インターナショナル・インク | A novel Trichoderma gene |
US7375197B2 (en) * | 2002-01-14 | 2008-05-20 | Midwest Research Institute | Cellobiohydrolase I gene and improved variants |
JP2011125341A (en) * | 2003-04-01 | 2011-06-30 | Genencor Internatl Inc | Variant humicola grisea cbh1.1 |
EP2357227A1 (en) | 2010-02-11 | 2011-08-17 | Süd-Chemie Ag | Optimized cellulase enzymes |
US8637293B2 (en) | 1999-07-13 | 2014-01-28 | Alliance For Sustainable Energy, Llc | Cellobiohydrolase I enzymes |
US9938551B2 (en) | 2012-12-12 | 2018-04-10 | Danisco Us Inc | Variants of cellobiohydrolases |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4472504A (en) * | 1983-03-28 | 1984-09-18 | The United States Of America As Represented By The Secretary Of The Army | Hyperproducing cellulase microorganism |
EP0133035A2 (en) * | 1983-07-27 | 1985-02-13 | Shin Nenryoyu Kaihatsu Gijutsu Kenkyu Kumiai | Process for the preparation of cellulase |
US5298405A (en) * | 1986-04-30 | 1994-03-29 | Alko Limited | Enzyme preparations with recombinantly-altered cellulose profiles and methods for their production |
US6114296A (en) * | 1992-10-06 | 2000-09-05 | Novo Nordisk A/S | Cellulase variants |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1338400C (en) * | 1983-08-31 | 1996-06-18 | David H. Gelfand | Recombinant fungal cellulases |
-
2000
- 2000-07-13 AU AU62108/00A patent/AU6210800A/en not_active Abandoned
- 2000-07-13 CA CA002379326A patent/CA2379326A1/en not_active Abandoned
- 2000-07-13 WO PCT/US2000/019007 patent/WO2001004284A1/en not_active Application Discontinuation
- 2000-07-13 EP EP00948637A patent/EP1200574A4/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4472504A (en) * | 1983-03-28 | 1984-09-18 | The United States Of America As Represented By The Secretary Of The Army | Hyperproducing cellulase microorganism |
EP0133035A2 (en) * | 1983-07-27 | 1985-02-13 | Shin Nenryoyu Kaihatsu Gijutsu Kenkyu Kumiai | Process for the preparation of cellulase |
US5298405A (en) * | 1986-04-30 | 1994-03-29 | Alko Limited | Enzyme preparations with recombinantly-altered cellulose profiles and methods for their production |
US6114296A (en) * | 1992-10-06 | 2000-09-05 | Novo Nordisk A/S | Cellulase variants |
Non-Patent Citations (1)
Title |
---|
See also references of EP1200574A4 * |
Cited By (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8637293B2 (en) | 1999-07-13 | 2014-01-28 | Alliance For Sustainable Energy, Llc | Cellobiohydrolase I enzymes |
US9187739B2 (en) | 2001-06-26 | 2015-11-17 | Novozymes A/S | Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
US9309504B2 (en) | 2001-06-26 | 2016-04-12 | Novozymes A/S | Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
US8338156B2 (en) | 2001-06-26 | 2012-12-25 | Novozymes A/S | Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
US8993299B2 (en) | 2001-06-26 | 2015-03-31 | Novozymes A/S | Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
US8986969B2 (en) | 2001-06-26 | 2015-03-24 | Novozymes A/S | Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
US9447399B2 (en) | 2001-06-26 | 2016-09-20 | Novozymes A/S | Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
US8603794B2 (en) | 2001-06-26 | 2013-12-10 | Novozymes A/S | Polypeptides having cellobiohydrolase 1 activity and polynucleotides encoding same |
US8603793B2 (en) | 2001-06-26 | 2013-12-10 | Novozymes A/S | Polypeptides having cellobiohydrolase 1 activity and polynucleotides encoding same |
US8507238B2 (en) | 2001-06-26 | 2013-08-13 | Novozymes A/S | Polypeptides having cellobiohydrolase 1 activity and polynucleotides encoding same |
US7785853B2 (en) | 2001-06-26 | 2010-08-31 | Novozymes A/S | Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
WO2003000941A3 (en) * | 2001-06-26 | 2004-03-25 | Novozymes As | Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
US7375197B2 (en) * | 2002-01-14 | 2008-05-20 | Midwest Research Institute | Cellobiohydrolase I gene and improved variants |
EP2295559A1 (en) * | 2002-08-16 | 2011-03-16 | Genencor International, Inc. | Novel variant hyprocrea jecorina CBH1 cellulases |
US8232080B2 (en) | 2002-08-16 | 2012-07-31 | Danisco Us Inc. | Variant Hyprocrea jecorina CBH1 cellulases |
EP2305800A1 (en) * | 2002-08-16 | 2011-04-06 | Genencor International, Inc. | Novel variant hyprocrea jecorina cbh1 cellulases |
EP1578943A2 (en) * | 2002-08-16 | 2005-09-28 | Genencor International, Inc. | NOVEL VARIANT i HYPROCREA JECORINA /i CBH1 CELLULASES |
JP2006515506A (en) * | 2002-08-16 | 2006-06-01 | ジェネンコー・インターナショナル・インク | Novel HyproCrea Jecolina CBH1 Cellulase |
EP2322607A1 (en) * | 2002-08-16 | 2011-05-18 | Genencor International, Inc. | Novel variant hyprocrea jecorina CBH1 cellulases |
EP2322606A1 (en) * | 2002-08-16 | 2011-05-18 | Genencor International, Inc. | Novel variant Hyprocrea jecorina CBH1 cellulases |
US8679817B2 (en) | 2002-08-16 | 2014-03-25 | Danisco Us Inc. | Variant Hypocrea jecorina CBH1 cellulase |
US8637294B2 (en) | 2002-08-16 | 2014-01-28 | Danisco Us Inc. | Variant Hypocrea jercorina CBH1 cellulases |
US7972832B2 (en) | 2002-08-16 | 2011-07-05 | Danisco Us Inc. | Variant Hypocrea jecorina CBH1 cellulases |
EP1578943A4 (en) * | 2002-08-16 | 2008-05-07 | Genencor Int | NOVEL VARIANT i HYPROCREA JECORINA /i CBH1 CELLULASES |
EP2305801A1 (en) * | 2002-08-16 | 2011-04-06 | Genencor International, Inc. | Novel variant hyprocrea jecorina CBH1 cellulases |
JP4756861B2 (en) * | 2002-08-16 | 2011-08-24 | ジェネンコー・インターナショナル・インク | Novel HyproCrea Jecolina CBH1 Cellulase |
JP2007534294A (en) * | 2003-03-21 | 2007-11-29 | ジェネンコー・インターナショナル・インク | CBH1 homologues and mutant CBH1 cellulases |
JP2011152136A (en) * | 2003-03-21 | 2011-08-11 | Genencor Internatl Inc | Cbh1 homolog and variant cbh1 cellulase |
EP2311942A1 (en) * | 2003-03-21 | 2011-04-20 | Genecor International, Inc. | Novel cbh1 homologs and variant cbh1 cellulases |
EP1606392A2 (en) * | 2003-03-21 | 2005-12-21 | Genencor International, Inc. | Novel cbh1 homologs and variant cbh1 cellulases |
EP2298876A1 (en) * | 2003-03-21 | 2011-03-23 | Genencor International, Inc. | Novel cbh1 homologs and variant cbh1 cellulases |
US8765440B2 (en) | 2003-03-21 | 2014-07-01 | Danisco Us Inc. | CBH1 homologs and varian CBH1 cellulase |
EP1606392A4 (en) * | 2003-03-21 | 2007-10-17 | Genencor Int | Novel cbh1 homologs and variant cbh1 cellulases |
US7951570B2 (en) | 2003-03-21 | 2011-05-31 | Danisco Us Inc. | CBH1 homologs and variant CBH1 cellulases |
JP2011125341A (en) * | 2003-04-01 | 2011-06-30 | Genencor Internatl Inc | Variant humicola grisea cbh1.1 |
JP4769724B2 (en) * | 2003-05-29 | 2011-09-07 | ジェネンコー・インターナショナル・インク | A novel Trichoderma gene |
JP2007521797A (en) * | 2003-05-29 | 2007-08-09 | ジェネンコー・インターナショナル・インク | A novel Trichoderma gene |
US7932073B2 (en) | 2003-08-25 | 2011-04-26 | Novozymes, Inc. | Variants of glycoside hydrolases |
EP2377931A1 (en) * | 2003-08-25 | 2011-10-19 | Novozymes Inc. | Variants of glycoside hydrolases |
EP1660637A4 (en) * | 2003-08-25 | 2009-10-21 | Novozymes Inc | Variants of glycoside hydrolases |
EP2617826A1 (en) * | 2003-08-25 | 2013-07-24 | Novozymes Inc. | Variants of glycoside hydrolases |
US8383385B2 (en) | 2003-08-25 | 2013-02-26 | Novozymes, Inc. | Variants of glycoside hydrolases |
EP1660637A2 (en) * | 2003-08-25 | 2006-05-31 | Novozymes Inc. | Variants of glycoside hydrolases |
US9701951B2 (en) | 2003-08-25 | 2017-07-11 | Novozymes, Inc. | Variants of glycoside hydrolases |
EP2357227A1 (en) | 2010-02-11 | 2011-08-17 | Süd-Chemie Ag | Optimized cellulase enzymes |
WO2011098551A3 (en) * | 2010-02-11 | 2012-05-31 | Süd-Chemie AG | Optimized cellulase enzymes |
US9458443B2 (en) | 2010-02-11 | 2016-10-04 | Sud-Chemie Ip Gmbh & Co. Kg | Optimized cellulase enzymes |
WO2011098551A2 (en) | 2010-02-11 | 2011-08-18 | Süd-Chemie AG | Optimized cellulase enzymes |
US9938551B2 (en) | 2012-12-12 | 2018-04-10 | Danisco Us Inc | Variants of cellobiohydrolases |
Also Published As
Publication number | Publication date |
---|---|
EP1200574A1 (en) | 2002-05-02 |
AU6210800A (en) | 2001-01-30 |
CA2379326A1 (en) | 2001-01-18 |
EP1200574A4 (en) | 2004-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4922524B2 (en) | Novel expression control sequences and expression products in the field of filamentous fungi | |
US7375197B2 (en) | Cellobiohydrolase I gene and improved variants | |
US8637293B2 (en) | Cellobiohydrolase I enzymes | |
CA2158357C (en) | Purification and molecular cloning of eg iii cellulase | |
EA018049B1 (en) | Heterologous and homologous cellulase expression system | |
JPH0767637A (en) | Xylanase derived from bacillus its expression vector and host living organism | |
US20030027298A1 (en) | Enzymatic array and process of making same | |
NZ253280A (en) | Recombinant truncated xylanases derived from anaerobic fungi | |
WO2001004284A1 (en) | Cellobiohydrolase reduced glycosylation variants: cbhin45a; cbhin270a; and cbhin384a | |
Posta et al. | Cloning, characterization and phylogenetic relationships of cel5B, a new endoglucanase encoding gene from Thermobifida fusca | |
US6268198B1 (en) | Cellulases and coding sequences | |
EP0815242A1 (en) | Endo beta-1,4-glucanase from aspergillus | |
CA2139099A1 (en) | Recombinant cellulases | |
US11371032B2 (en) | Beta glucosidase with high glucose tolerance, high thermal stability and broad PH activity spectrum | |
US11225679B2 (en) | Mutant β-glucosidase | |
Adney et al. | Cellobiohydrolase I gene and improved variants | |
AU696724B2 (en) | Recombinant xylanase | |
RU2358756C1 (en) | Method of producing enzymatic agent for degradation of hemicellulose heteropolysaccharides of herbal cytoderm and enzymatic agent (versions) | |
EP2885407B1 (en) | Pectin degrading enzymes from macrophomina phaseolina and uses thereof | |
KR20140048904A (en) | Cellulase fusion protein and method of degrading cellulosic material using the same | |
KAYDAMOV et al. | Expression of three β-glucosidase genes from Arthrobacter SP. GJM-1 in Escherichia coli | |
MXPA97007112A (en) | Endo-beta-1,4-glucanase from aspergil | |
MXPA01003462A (en) | Transformation system in the field of filamentous fungal hosts | |
JPH03251174A (en) | Cellulase ae-1, dna fragment containing cellulase ae-1 gene and production of cellulase ae-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2379326 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000948637 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000948637 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000948637 Country of ref document: EP |